Oscar Health stock steadies premarket after ACA subsidies vote; UBS lifts rating
Oscar Health shares traded flat at $16.90 premarket Friday after a 2.6% rally Thursday, as investors watched House action on ACA subsidies and a UBS upgrade. UBS raised Oscar to neutral, citing steadier exchange enrollment. CTO Mario Schlosser sold 76,962 shares this week under a preset plan. The House-passed subsidy bill now moves to the Senate, with negotiations ongoing.